
|Videos|February 17, 2023
Strategies for Mitigating Cardiovascular Risk
Comprehensive insight regarding strategies to mitigate cardiovascular risk in patients on therapy for prostate cancer.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Focal therapy for prostate cancer frequently used outside guideline-supported groups
2
Active surveillance use for low-risk prostate cancer reaches 93% in VA System
3
Real-world data support PSA below 0.2 ng/mL as key response threshold in mCSPC
4
Published LITESPARK-011 data show PFS benefit with belzutifan plus lenvatinib in ccRCC
5















